Marquette University
Trial Pipeline
Determinants of Bone Dimensional Changes After Extraction and Alveolar Ridge Preservation
NCT06624982
Mental Imagery to Improve Quadriceps Strength Post Anterior Cruciate Ligament Reconstruction: a Feasibility Study
NCT06858293
Computer-guided Action Planning to Support Physical Activity (CAPPA) for Employees with Chronic Knee Symptoms
NCT06734052
Exercise Training in Children With Communication Impairments
NCT06340893
Preemptive Ibuprofen Effects on Pain Perception Following Extraction and Bone Graft
NCT05919745
Perception of Speech in Context by Listeners With Healthy and Impaired Hearing
NCT06465979
CUped: An Approach to Motor Recovery Post-Stroke, Not Compensation
NCT06329765
Use of Sensory Substitution to Improve Arm Control After Stroke
NCT03298243
High-Intensity, Dynamic-stability Gait Training in People With Multiple Sclerosis
NCT05735691
Life After Sport: Prior Injury and Sedentary Behavior as Mechanisms of Later Poor Health
NCT05344001
Fatigability of Lower Limb Muscle in Older Adults: Protective Effects of Strength Training Exercise in Old Men and Women
NCT03888040
Dose Frequency RCT on DTTC in Children With CAS
NCT05675306
The Efficacy of Probiotics to Reduce Antepartum Group B Streptococcus Colonization.
NCT03696953
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 4 | 29 |
What the Pipeline for Marquette University Shows
According to the ClinicalTrials.gov registry, Marquette University is linked to 41 US clinical trials across every stage of research activity. Of those, 39 studies are currently recruiting — about 95% of the sponsor's indexed portfolio — and 0 are already marked complete, representing roughly 0% of the total. Recruiting share is one of the more practical signals here: it reflects how much of a sponsor's research is presently open to new participants, while the completed share indicates the depth of finished work that has already contributed registry results. Both counts come directly from the public ClinicalTrials.gov dataset and are refreshed on the registry side; this page mirrors the latest data pull without altering it.
The phase mix for Marquette University reports 29 late-stage studies (Phase 3 and Phase 4 combined) and 1 earlier-phase studies (Phase 1 and Phase 2). A portfolio weighted toward Phase 3 usually reflects an organization advancing candidates toward regulatory review, where the research centers on comparative efficacy and broader safety across larger populations. A heavier Phase 1 and Phase 2 tilt generally indicates exploratory work — safety, dosing, and early signal detection — and is common among research-forward sponsors that seed many early programs. Phase 4 entries, when present, track interventions already in real-world use and typically focus on long-term safety, effectiveness across subgroups, or formulation comparisons.
The top therapeutic focus area indexed for Marquette University is Aging with 2 linked trials, and 9 other condition areas appear in the top list above. That distribution is a quick read of where the organization concentrates its research attention; it does not imply product availability, market share, or any clinical endorsement. All numbers on this page come from ClinicalTrials.gov maintained by the National Library of Medicine, and counts can shift as new studies are registered or existing ones update their status. This information is provided for reference and educational purposes only, not as medical, investment, or regulatory advice — verify current details directly with ClinicalTrials.gov before relying on any figure here.
Read our methodology — how this data is sourced, computed, and verified.